Israeli researchers have found that low levels of Vitamin D in the blood are associated with an increased risk of Covid-19 infection. Vitamin D is a hormone, produced in the skin during exposure to sunlight, and helps regulate the amount of calcium and phosphate in the body, which are needed to keep bones, teeth and […]
A recent study found that the novel coronavirus appears to have circulated unnoticed in bats for decades. Horseshoe bats are the most plausible origin of the SARS-CoV-2 pathogen, researchers led by Maciej Boni of Pensylvania State University’s Center for Infectious Disease Dynamics. Daily Current Affairs Quiz 2020 Key-Points Bats have been the ‘primary reservoirs’ for
SARS-CoV-2 circulated unnoticed in bats for decades Read More »
Germany’s Biotechnology Company BioNTech and China’s Shanghai Fosun Pharmaceutical have announced the start of another COVID-19 vaccine trial in China. BioNTech and Fosun Pharma are jointly developing the COVID-19 vaccine candidate in China. Daily Current Affairs Quiz 2020 Key-Points The randomized, placebo-controlled, observer-blinded Phase 1 clinical trial in China will enroll 144 healthy subjects to
BioNTech and Fosun Pharma to start clinical trial of COVID-19 Vaccine in China Read More »
Singapore has sought out U.S. Covid-19 vaccine developer Arcturus Therapeutics Holdings Inc. and is funding its research in order to secure the first doses of any successful final product, in a reflection of the growing urgency in the race for immunization. Daily Current Affairs Quiz 2020 Key-Points As with many vaccine makers seeking a shot
Singapore to have the first right to Arcturus’ covid vaccine Read More »
A Russian state virology institute has started human trials of the country’s second potential COVID-19 vaccine, injecting the first of five volunteers with a dose on July 27. The next volunteer in the trial by the Vector virology institute in Siberia would receive an injection on July 30. Daily Current Affairs Quiz 2020 Key-Points A
Russia’s second covid vaccine goes into human trial Read More »
Defence Institute of Advanced Technology, (DIAT), Pune has developed a Medical Bed Isolation System named Aashray to combat COVID-19 by stopping/ minimizing the spread of virus/ infection released by the patient. This is a low cost, reusable solution to maintain proper isolation of COVID-19 patients by creating suction /negative pressure near exhale, and further filtering
DIAT develops medical bed isolation system for covid-19 patients Read More »
A government supported IT company in Bengaluru has developed an application named Lyfas which is capable of capturing an individual’s vital health statistics through mobile phone to determine one’s propensity to Covid 19 infection and can potentially play a big role in early detection of disease and risk assessment of infected population, according to a
India develops Covid 19 detecting mobile app Lyfas Read More »
Prime Minister Modi has launched high throughput COVID-19 testing facilities on 27th July via video conferencing. These facilities will ramp up testing capacity in the country and help in strengthening early detection and treatment, thus assisting in controlling the spread of the pandemic. Daily Current Affairs Quiz 2020 Key-Points These three high-throughput testing facilities have
PM to launch High Throughput COVID-19 testing facilities Read More »
The spike protein of the COVID-19-causing SARS-CoV-2 has been found to change its form once it attaches itself to the human cell. Researchers have found that once the coronavirus binds itself to the human cell with the help of these spike proteins, the proteins fold in on themselves to take a rigid hairpin shape, a
Covid-19 changes shape in human body and decoys immunity Read More »
DBT-BIRAC has facilitated the establishment of ‘first-of-its-kind’ mRNA-based vaccine manufacturing platform in India. DBT has provided seed funding for the development of Gennova’s novel self-amplifying mRNA-based vaccine candidate for COVID19. Daily Current Affairs Quiz 2020 Key-Points In collaboration with HDT Biotech Corporation, Seattle, USA, Gennova has developed an mRNA vaccine candidate (HGCO19), with demonstrated safety,
mRNA based vaccine manufacturing platform in India Read More »
